Hot Pursuit     30-Jun-23
Solara Active Pharma board to mull rights issue proposal on July 5
Solara Active Pharma Sciences has announced that its board is scheduled to be held on Wednesday, 5 July 2023, to consider the proposal to issue equity shares to existing shareholders on rights basis.

The announcement was made during market hours today.

Solara Active Pharma Sciences engaged in the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients.

The company's consolidated net profit surged to Rs 3.77 crore in the quarter ended March 2023 as against Rs 1.88 crore during the previous quarter ended March 2022. Sales rose 5.49% to Rs 380.62 crore in Q4 FY23 over Q4 FY22.

The scrip added 0.70% to currently trade at Rs 383.20 on the BSE.

Previous News
  Solara Active Pharma Sciences reports consolidated net loss of Rs 255.34 crore in the March 2024 quarter
 ( Results - Announcements 29-May-24   17:02 )
  Solara Active Pharma spurts 17% in four sessions
 ( Hot Pursuit - 26-Nov-21   15:27 )
  Board of Solara Active Pharma Sciences approves change in directorate
 ( Corporate News - 04-Aug-21   18:17 )
  Solara Active Pharma Sciences fixes record date for interim dividend
 ( Market Beat - Reports 06-Nov-20   20:29 )
  Solara Active Pharma Sciences consolidated net profit rises 87.01% in the December 2019 quarter
 ( Results - Announcements 06-Feb-20   15:12 )
  Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility
 ( Corporate News - 27-Jan-23   10:16 )
  Solara Active Pharma rallies 24% in three days
 ( Hot Pursuit - 18-Feb-22   14:43 )
  Solara Active Pharma Sciences consolidated net profit rises 217.90% in the March 2021 quarter
 ( Results - Announcements 06-May-21   16:07 )
  Solara Active Pharma Sciences to conduct board meeting
 ( Corporate News - 28-Jul-21   12:37 )
  Solara Active Pharma Sciences finalizes terms of proposed rights issue
 ( Corporate News - 10-May-24   09:23 )
  Board of Solara Active Pharma Sciences recommends final dividend
 ( Corporate News - 07-May-20   17:24 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top